This event is archived. Final snapshot from when the story concluded. View on Dashboard
Tech medical study

Oxford Study Reassures on Statin Safety

Analysis based on 28 articles · First reported Feb 06, 2026 · Last updated Feb 17, 2026

Sentiment
60
Attention
4
Articles
28
Market Impact
Direct
Live prominence charts, article sentiment distribution, and event development timeline available on the NewsDesk Dashboard

The study's findings are expected to increase patient confidence in statins, potentially leading to higher prescription rates and improved public health outcomes. This positive sentiment could benefit pharmaceutical companies producing statins and healthcare providers.

Pharmaceuticals Healthcare

A major study led by the University of Oxford's Cholesterol Treatment Trialists' Collaboration, involving 23 randomized trials and over 150,000 participants, found that most commonly reported statin side effects are not directly caused by the medication. Researchers, including Christina Reith and Rory Collins, concluded that statins are safe and effective, with only minor increases in abnormal liver blood tests and a slight rise in blood sugar levels for those at high risk of diabetes. Bryan Williams of the British Heart Foundation emphasized the importance of these findings in countering misinformation and preventing cardiovascular deaths. The study calls for a rapid revision of statin warning labels to better inform patients and doctors.

90 University of Oxford published major review on statin safety The Lancet
90 Christina Reith led study on statin side effects
90 University of Oxford conducted major randomized studies on statin safety
85 Rory Collins co-authored study and called for label revisions
85 Christina Reith led the study on statin side effects
80 Rory Collins called for revision of statin product labels
70 British Heart Foundation part-funded statin safety study University of Oxford
70 Bryan Williams endorsed study findings and called for increased statin use
+ 3 more actions View on Dashboard
ngo
The University of Oxford's Oxford Population Health coordinated the Cholesterol Treatment Trialists' Collaboration, which conducted this significant study on statin safety.
Importance 90 Sentiment 50
per
Christina Reith is the lead author of the study, providing reassurance about statin safety and highlighting their life-saving benefits.
Importance 80 Sentiment 50
per
Rory Collins, senior author, called for rapid revision of statin product labels to reflect the study's findings, enabling better-informed health decisions.
Importance 80 Sentiment 50
ngo
The British Heart Foundation provided funding for the study and its Chief Scientific and Medical Officer, Bryan Williams, endorsed the findings as crucial for patient reassurance.
Importance 80 Sentiment 50
per
Bryan Williams, representing the British Heart Foundation, emphasized the importance of the findings in countering misinformation about statins and preventing cardiovascular deaths.
Importance 70 Sentiment 50
govactor
The Australia===National Health and Medical Research Council provided funding for the statin safety study.
Importance 60 Sentiment 50
govactor
United Kingdom===UK Research and Innovation (UKRI) Medical Research Council provided funding for the statin safety study.
Importance 60 Sentiment 50
+ 3 more entities View on Dashboard
NEWSDESK
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.